X0508 4 2024-09-01 false 0001568651 Oscar Health, Inc. OSCR 0001844320 Schlosser Mario 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 true true false false President of Technology & CTO false Class A Common Stock 2024-09-01 4 M false 14412.00 A 80180.00 D Class A Common Stock 2024-09-03 4 S false 3198.00 17.99 D 76982.00 D Class A Common Stock 2024-09-04 4 S false 1605.00 17.46 D 75377.00 D Class A Common Stock 2024-09-04 4 S false 1311.00 17.85 D 74066.00 D Restricted Stock Unit 2024-09-01 4 M false 14412.00 0.00 D Class A Common Stock 14412.00 144117.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. /s/ Melissa Curtin, Attorney-in-fact 2024-09-04